Enjoy complimentary customisation on priority with our Enterprise License!
The organs on chips market share is expected to increase to USD 73.91 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 29.34%.
This organs on chips market research report extensively cover organs on chips market segmentations by type (lung, liver, heart, kidney, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The organs on chips market report also offers information on several market vendors, including Allevi Inc., Altis Biosystems Inc., AxoSim Inc., BICO Group AB, BiomimX Srl, BIonD Solutions BV, CN Bio Innovations Ltd., Elveflow, Emulate Inc., Hesperos Inc., InSphero AG, Kirkstall Ltd., MIMETAS BV, NETRI, Nortis Inc., SynVivo Inc., TARA Biosystems Inc., and TissUse GmbH among others.
Download the Free Report Sample to Unlock the Organs on Chips Market Size for the Forecast Period and Other Important Statistics
The increasing prevalence of chronic disorders is notably driving the organs on chips market growth, although factors such as high cost of organ-on-chip may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the organs on chips industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Organs on Chips Market Driver
one of the key factors driving the global organs on chips (OOC) growth is the increasing prevalence of chronic disorders. According to the CDC 2020 report, about 795,000 people in the US suffer a stroke each year. Furthermore, an estimated 92.1 million US adults have at least one form of CVD. By 2030, 43.9% of the US adult population is projected to have some form of CVD. Globally, 80% of CVD mortality takes place in low and middle-income countries and occurs almost equally in men and women. In addition, according to the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than 661,000 people in the US have kidney failure, 468,000 individuals are on dialysis, and roughly 193,000 live with a functioning kidney transplant. Such factors will drive the growth of the market during the forecast period.
Key Organs on Chips Market Challenge
one of the key challenges to the global OOC market growth is the high cost of organ-on-chip. The overall cost of organs-on-chips includes the cost of the surgical procedure, device and console, and continuing medical surveillance. The total organs-on-chips cost about USD 330 to USD 2700 a year to maintain. Furthermore, most of these devices are not covered by insurance. Due to the high cost, the adoption rate of organ-on-chip is significantly lower in developing economies. Additionally, end-users from a few developing countries such as India, Brazil, and Iran have low awareness of technologically advanced organs-on-chips and low purchasing power. Such factors will hamper the potential growth of the global organs-on-chips market during the forecast period.
Key Organs on Chips Market Trend
Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers is one of the key organs on chips market trends that is expected to impact the industry positively in the forecast period. For instance, in 2020, CN Bio and Imperial College London collaborated to harness CN Bio's liver-on-chip technology to advance the understanding of the underlying mechanisms of alcoholic hepatitis and uncover novel targets for drug discovery and development. In October 2020, the United States Food and Drug Administration entered a collaborative agreement to use lung chips from Emulate Inc. to evaluate the safety of COVID-19 vaccines and protective immunity against SARS-CoV-2. In October 2020, researchers at the US Army Combat Capabilities Development Command (CCDC) and Chemical Biological Center (CBC) used Emulat's lung-on-chip technology for research on COVID-19. Such factors are expected to further support the growth of the market during the forecast years.
This organs on chips market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the organs on chips market encompasses successful business strategies deployed by the key vendors. The organs on chips market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The organs on chips market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
35% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for organs on chips in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The availability of a wide range of services offered by major players and an increase in toxicological testing of chemicals on the different types of organ cells will facilitate the organ on chips market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the outbreak of COVID-19 severely impacted the organ-on-chip market in North America. The exponential rise in the number of COVID-19 cases compelled the governments of various countries in the region to impose restrictions on businesses and transportation activities, which led to the closure of manufacturing units and affected the distribution of organs on chips. However, in 2021, the introduction of COVID-19 vaccines resulted in the lifting of lockdowns and the rescheduling of surgical operations in the region. Such factors are expected to drive the growth of the regional market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The organ on chips market share growth by the lung segment will be significant during the forecast period. The growing awareness and demand for lungs on chips are expected to positively impact the growth of the global organs-on-chips market in the coming years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the organs on chips market size and actionable market insights on post COVID-19 impact on each segment.
Our report provides extensive information on the value chain analysis for the organs on chips market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Technavio categorizes the global organs-on-chips market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the organs on chips market during the forecast period.
|
Organs on Chips Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 29.34% |
|
Market growth 2022-2026 |
$ 73.91 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
28.24 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 35% |
|
Key consumer countries |
US, Canada, Germany, France, and Japan |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Allevi Inc., Altis Biosystems Inc., AxoSim Inc., BICO Group AB, BiomimX Srl, BIonD Solutions BV, CN Bio Innovations Ltd., Elveflow, Emulate Inc., Hesperos Inc., InSphero AG, Kirkstall Ltd., MIMETAS BV, NETRI, Nortis Inc., SynVivo Inc., TARA Biosystems Inc., and TissUse GmbH |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
